PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. [electronic resource]
Producer: 20030321Description: E531-40 p. digitalISSN:- 0193-1849
- Animals
- Dietary Fats -- administration & dosage
- Fatty Liver -- drug therapy
- Glucose -- metabolism
- Glucose Clamp Technique
- Insulin -- metabolism
- Insulin Resistance
- Lipid Metabolism
- Liver -- metabolism
- Male
- Muscle, Skeletal -- metabolism
- Oxazines -- therapeutic use
- Phenylpropionates -- therapeutic use
- Pyrimidines -- therapeutic use
- Rats
- Rats, Wistar
- Receptors, Cytoplasmic and Nuclear -- agonists
- Rosiglitazone
- Thiazoles -- therapeutic use
- Thiazolidinediones
- Transcription Factors -- agonists
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.